Voltar
Revisão
BIBTEX RIS

CALCIUM ENTRY BLOCKING DRUGS, ‘CALCIUM ANTAGONISTS’ AND VASCULAR SMOOTH MUSCLE FUNCTION

1983; Wiley; Volume: 3; Issue: 3 Linguagem: Inglês

10.1111/j.1474-8673.1983.tb00538.x

ISSN

1365-2680

Autores

Josep Bou, Jesús Llenas, R. Massingham,

Tópico(s)

Vitamin C and Antioxidants Research

Resumo

Journal of Autonomic PharmacologyVolume 3, Issue 3 p. 219-232 CALCIUM ENTRY BLOCKING DRUGS, 'CALCIUM ANTAGONISTS' AND VASCULAR SMOOTH MUSCLE FUNCTION J. BOU, J. BOU Department of Pharmacology, Institute of Investigation Laboratorios Almirall, Cardoner 68–74, Barcelona-24, Spain.Search for more papers by this authorJ. LLENAS, J. LLENAS Department of Pharmacology, Institute of Investigation Laboratorios Almirall, Cardoner 68–74, Barcelona-24, Spain.Search for more papers by this authorR. MASSINGHAM, R. MASSINGHAM Department of Pharmacology, Institute of Investigation Laboratorios Almirall, Cardoner 68–74, Barcelona-24, Spain.Search for more papers by this author J. BOU, J. BOU Department of Pharmacology, Institute of Investigation Laboratorios Almirall, Cardoner 68–74, Barcelona-24, Spain.Search for more papers by this authorJ. LLENAS, J. LLENAS Department of Pharmacology, Institute of Investigation Laboratorios Almirall, Cardoner 68–74, Barcelona-24, Spain.Search for more papers by this authorR. MASSINGHAM, R. MASSINGHAM Department of Pharmacology, Institute of Investigation Laboratorios Almirall, Cardoner 68–74, Barcelona-24, Spain.Search for more papers by this author First published: September 1983 https://doi.org/10.1111/j.1474-8673.1983.tb00538.xCitations: 46AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References BAYER, R., EHARA, T. (1977). Comparative studies on calcium antagonists. Prog. Pharmac., 2, 31–37. Google Scholar BAYER, D., KALUSCHE, D., KAUFMANN, R. & MAN-NHOLD, R. (1975). Inotropic and electrophysiological actions of verapamil and D-600 in mammalian myocardium. III. Effects of the optical isomers on transmem-brane action potentials. Naunyn-Schmied. Arch. Pharmac., 290, 81–97. 10.1007/BF00499991 CASPubMedWeb of Science®Google Scholar BELLEMANN, P., FERRY, D., LUBBECKE, F. & GLOSSMANN, H. (1981). [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Arzn. Forsch., 31, 2064–2067. CASPubMedWeb of Science®Google Scholar BEVAN, J. A., BEVAN, R. D., HWA, J. J., OWEN, M. P., TAYO, F. M. & WINQUIST, R. J. (1982). Calcium, extrinsic and intrinsic (myogenic) vascular tone. In Calcium modulators (Eds. T. Godfraind, A. Albertini & R. Paoletti) Elsevier/North Holland, Amsterdam . 125–132. Google Scholar BLEEKER, A. & Van ZWIETEN, P. A. (1978). The negative inotropic effect of verapamil. Prog. Pharmac., 2, 39–49. CASGoogle Scholar BOHR, D. F. (1963). Vascular smooth muscle: dual effect of calcium. Science, 139, 579–599. 10.1126/science.139.3555.597 Web of Science®Google Scholar BOHR, D. F. (1973). Vascular smooth muscle updated. Circulation Res., 32, 665–672. 10.1161/01.RES.32.6.665 CASPubMedWeb of Science®Google Scholar BOLTON, T. B. (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol. Rev., 59, 606–718. 10.1152/physrev.1979.59.3.606 CASPubMedWeb of Science®Google Scholar BROEKAERT, A. & GODFRAIND, T. (1979). A comparison of the inhibitory effect of cinnarizine and papaverine on the noradrenaline- and calcium-evoked contraction of isolated rabbit aorta and mesenteric arteries. Eur.J. Pharmac., 53, 281–288. 10.1016/0014-2999(79)90134-1 CASPubMedWeb of Science®Google Scholar CASTEELS, R. (1980). Electro- and Pharmacomechanical coupling in vascular smooth muscle. Chest., 78, (Supplement) 150–156. 10.1378/chest.78.1_Supplement.150 CASPubMedWeb of Science®Google Scholar CAUVIN, C., LOUTZENHISER, R., HWANG, O. & Van BREEMEN, C. (1982). α1-adrenoreceptors induce Ca-influx and intracellular Ca release in isolated rabbit aorta. Eur.J. Pharmac., 84, 233–235. 10.1016/0014-2999(82)90209-6 CASPubMedWeb of Science®Google Scholar CAVERO, I. & LEFEVRE-BORG, F. (1981). Effects of dil-tiazem and verapamil on pressor responses mediated by stimulation of α1-,α2-adrenoceptors, angiotensin-II and 5-hydroxytrptamine receps in pithed rats. Br. J. Pharmac, 74, 893P. Google Scholar CHURCH, J. & ZSOTER, T. T. (1980). Calcium antagonist drugs. Mechanism of action. Canad. J. Physiol. Pharmac., 58, 254–264. 10.1139/y80-044 CASPubMedWeb of Science®Google Scholar CORABOEUF, E. (1978). Ionic basis of electrical activity in cardiac tissues. Am.J. Physiol., 234, 101–116. CASPubMedWeb of Science®Google Scholar CORABOEUF, E. (1979). Proceedings 4th International Adalat Symposium ( P Eds Puech & R. Krebs), Excerpta Medica, Amstedam , 3–13. Google Scholar DE JONGE, A., WILFFERT, B., KALKMAN, H. O., Van MEEL, J. C. A., THOOLEN, J. M. C, TIM-MERMANS, P. B. M. W. M. & Van ZWIETEN, P. A. (1981). Captopril impairs the vascular smooth muscle contraction mediated by postsynaptic α2-adrenoceptors in the pithed rat. Eur.J. Pharmac., 74, 385–386. 10.1016/0014-2999(81)90061-3 PubMedWeb of Science®Google Scholar DE MEY, J. & VANHOUTTE, P. M. (1981). Uneven distribution of postjunctional alpha1- and alpha2- like adrenoceptors in canine arterial and venous smooth muscle. Circulation Res., 48, 875–884. 10.1161/01.RES.48.6.875 PubMedWeb of Science®Google Scholar DETH, R. C. & CASTEELS, R. (1977). A study of releasa-ble Ca fractions in smooth muscle cells of the rabbit aorta. J. Gen. Physiol., 69, 401–416. 10.1085/jgp.69.4.401 CASPubMedWeb of Science®Google Scholar DETH, R. & Van BREEMEN, C. (1977). Agonist induced 45Ca2+ release from smooth muscle cells of the rabbit aorta. J. Memb. Biol., 30, 363–380. 10.1007/BF01869677 CASPubMedWeb of Science®Google Scholar DEVINE, C. E., SOMLYO, A. V. & SOMLYO, A. P. (1972). Sarcoplasmic reticulum and excitation-contraction coupling in mammalian smooth muscle. J. Cell. Biol., 52, 690–718. 10.1083/jcb.52.3.690 PubMedWeb of Science®Google Scholar EHLERT, F. J., ITOGA, E., ROESKE, W. R. & YAMAM-URA, H. I. (1982). The interaction of [3H] nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. Biochem. Biophys. Res. Commun., 104, 937–944. 10.1016/0006-291X(82)91339-0 CASPubMedWeb of Science®Google Scholar FERRY, D. R. & GLOSSMANN, H. (1982). Evidence for multiple receptor sites within the putative calcium channel. Naunyn-Schmied. Arch. Pharmac., 321, 80–83. 10.1007/BF00586355 CASPubMedWeb of Science®Google Scholar FLECKENSTEIN, A. (1977). Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Am. Rev. Pharmac. Toxicol., 17, 149–166. 10.1146/annurev.pa.17.040177.001053 CASPubMedWeb of Science®Google Scholar FLECKENSTEIN, A. (1982). Basic membrane actions of calcium antagonists with special reference to verapamil. In Calcium Modulators (Eds. T. Godfraind, A. Albertini & R Paoletti). Elsevier/North Holland. Amsterdam , 297–310. Google Scholar FLECKENSTEIN, A., NAKAYAMA, K., FLECKENS-TEIN-GRUN, G. & BYON, Y. K. (1975). Interaction of vasoactive ions and drugs with Ca -dependent excitation-contraction coupling of vascular smooth muscle. In: Calcium Transport in Contraction and Secretion. (ed. E Carafoli) North Holland. Amsterdam . 555–556. Google Scholar FLECKENSTEIN, A., TRITTHART, H. & DORING, H. J. (1972). Bay a 1040-ein hochaktiver Ca++-antagonis-tischer inhibitor der elektro-mechanischen Koppelungs prozesse im Warmbluter-Myokard. Arzn. Forsch., 22, 22–33. CASPubMedWeb of Science®Google Scholar FLECKENSTEIN, A., TRITTHART, H., FLECKENSTEIN, B., HERBST, A. & GRUN, G. (1969). A new group of competitive Ca antagonists (iproverapamil, D-600, prenylamine) with highly potent inhibitory effects on excitation-contraction coupling in mammalian myocardium. Pflugers Arch., 307, R.25. CASGoogle Scholar GARGOUIL, Y. M. (1981). Cardioactive drugs and the calcium slow channel in the heart. Trends in Pharmac. Sci., 2, 44–47. 10.1016/0165-6147(81)90258-3 CASWeb of Science®Google Scholar GARGOUIL, Y. M. (1982). Pharmacologie du canal lent 'cal-cique'. J. Pharmac. (Paris). 13, Suppl. 1, 29–44. CASGoogle Scholar GILLIS, J. M. (1982). Similarities and differences in excitation-contraction in the various types of muscle cells. In: Calcium Modulators (Eds. T. Godfraind, A. Albertini & Paoletti), Eisevier/North Holland. Amsterdam , 29–38. Google Scholar GLOSSMANN, H., FERRY, D. R., LUBBECKE, F., MEWES, R. & HOFMANN, F. (1982). Calcium channels: direct identification with radiological binding studies. Trends in Pharmac. Sci., 3, 431–437. 10.1016/0165-6147(82)91221-4 CASWeb of Science®Google Scholar GODFRAIND, T. (1976). Calcium exchange in vascular smooth muscle, action of noradrenaline and Lanthanum. J. Physiol. (Lond.), 260, 21–35. 10.1113/jphysiol.1976.sp011501 CASPubMedWeb of Science®Google Scholar GODFRAIND, T. (1981). Mechanisms of action of calcium entry blockers. Fed. Proc., 40, 2866–2871. CASPubMedWeb of Science®Google Scholar GODFRAIND, T. (1982). Pharmacology of calcium entry blockers. In: Calcium Modulators (Eds. T. Godfraind, A. Albertini & R. Paoletti) Elseveir/North Holland. Amsterdam . 51–66. Google Scholar GODFRAIND, T. & DIEU, D. (1981). The inhibition by flunarizine of the norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries. J. Pharmac. exp. Ther., 217, 510–515. CASPubMedWeb of Science®Google Scholar GODFRAIND, T. & KABA, A. (1972). The role of calcium in the action of drugs in vascular smooth muscle. Arch. Int. Pharmacodyn. Therap., 196, 35–49. PubMedWeb of Science®Google Scholar GODFRAIND, T. & MILLER, R. C. (1982). Action of prostaglandin F2α and noradrenaline on Ca exchange and contraction in rat mesenteric arteries. Br. J. Pharmac., 75, 229–236. 10.1111/j.1476-5381.1982.tb08777.x CASPubMedWeb of Science®Google Scholar GODFRAIND, T., MILLER, R. C. & SOCRATES LIMA, J. (1982). Selective α1- and α2-adrenoceptor agonist- induced contractions and 45Ca fluxes in the rat isolated aorta. Br. J. Pharmac., 77, 597–604. 10.1111/j.1476-5381.1982.tb09337.x CASPubMedWeb of Science®Google Scholar GODFRAIND, T. & MOREL, N. (1981). Identification of the specific binding of flunarizine to rat aorta. Br.J. Pharmac., 72, 517P. Google Scholar GOLENHOFEN, K. (1979). Differentiation of calcium activation processes in smooth muscle using selective antagonists. In: Smooth muscle II ( E. Bulbring, A. Brading, A. W. Jones T. Tomita eds). Edward Arnold. Web of Science®Google Scholar HAEUSLER, G. (1972). Differential effects of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals. J. Pharmac. exp. Ther., 180, 672–682. CASPubMedWeb of Science®Google Scholar HAEUSLER, G., RICHARD, J. G. & THORENS, S. (1981). Noradrenaline contraction in rabbit arteries skinned with saponin. J. Physiol (Lond.), 321, 537–556. 10.1113/jphysiol.1981.sp014001 CASPubMedWeb of Science®Google Scholar HENRY, P. D. (1980). Comparative pharmacology of calcium antagonists: nifedipine, verapamil, diltiazem. Am. J. Cardiol., 46, 1047–1058. 10.1016/0002-9149(80)90366-5 CASPubMedWeb of Science®Google Scholar HESCHELER, J., PELZER, D., TRUBE, G., & TRAUT-WEIN, W. (1982). Does the organic calcium channel blocker D-600 act from inside or outside on the cardiac cell membrane Pflugers. Archiv., 393, 287–291. 10.1007/BF00581411 CASPubMedWeb of Science®Google Scholar HOF, R. P. (1983). Calcium antagonists and the peripheral circulation: differences and similarities between PY 108–068, nicardipine, verapamil and diltiazem. Br. J. Pharmac., 78, 375–394. 10.1111/j.1476-5381.1983.tb09403.x CASPubMedWeb of Science®Google Scholar HOLCK, M., THORENS, A. & HAEUSLER, G. (1982). Characterization of (3H) Nifedipine binding sites in rabbit myocardium. Eur. J. Pharmac., 85, 305–315. 10.1016/0014-2999(82)90217-5 CASPubMedWeb of Science®Google Scholar JETLEY, M. & WESTON, A. H. (1980). Some effects of sodium nitroprusside, methoxyverapamil (D-600) and nifedipine on rat portal vein. Br. J. Pharmac., 68, 311–319. 10.1111/j.1476-5381.1980.tb10420.x CASPubMedWeb of Science®Google Scholar KAIMAN, M. & SHIBATA, S. (1978). Calcium influx and spontaneous phasic contractions of portal veins after treatment with reserpine, 6-hydroxydopamine and cocaine. Canad. J. Physiol. Phamac, 56, 199–201. 10.1139/y78-028 CASPubMedWeb of Science®Google Scholar KAZDA, S., GARTHOFF, B., KRAUSE, H. P. & SCHLOSSMAN, K. (1982). Cerebrovascular effects of the calcium antagonist dihydropyridine derivative Nimodipine in animal experiments. Arzn. Forsch., 32, 331–338. CASPubMedWeb of Science®Google Scholar KENTISH, J. C. & NAYLER, W. G. (1978). Ca2+-dependent tension generation in chemically skinned cardiac trabeculae. J. Physiol. (Lond.), 264, 90P. Google Scholar KOBINGER, W. & PICHLER, L. (1981). α2-Adrenoceptor agonist effect of B-HT 920 in isolated perfused hindquarters of rats. Eur.J. Pharmac., 76, 101–105. 10.1016/0014-2999(81)90016-9 CASPubMedWeb of Science®Google Scholar LANGER, S. Z., MASSINGHAM, R. & SHEPPERSON, N. B. (1981). Preferential, long-lasting blockade of neuronally released but not exogenously administered noradrenaline in vitro: further evidence that the α1-adrenoceptor subtype predominates intrasynaptically. Br. J. Pharmac., 73, 281–282P. Google Scholar LANGER, S. Z. & SHEPPERSON, N. B. (1982). Recent developments in vascular smooth muscle pharmacology; the post-synaptic α2-adrenoceptor. Trends in Pharmac. Sci., 3, 440–444. 10.1016/0165-6147(82)91223-8 CASWeb of Science®Google Scholar LANGER, S. Z., SHEPPERSON, N. B. & MASSIN-GHAM, R. (1981). Preferential noradrenergic innervation of alpha-1 adrenergic receptors in vascular smooth muscle. Hypertension (Suppl. 1), 3, 112–118. 10.1161/01.HYP.3.3_Pt_2.I112 CASGoogle Scholar LLENAS, J. & MASSINGHAM, R. (1983a). A comparison of the effects of verapamil and cinnarizine upon responses elicited by selective α1- and α2-adrenoceptor agonists in the autoperfused canine hindlimb. Eur. J. Pharmac., 87, 53–59. 10.1016/0014-2999(83)90049-3 CASPubMedWeb of Science®Google Scholar LLENAS, J. & MASSINGHAM, R. (1983b). Effects of verapamil and cinnarizine on canine hindlimb pressor responses to α-adrenoceptor agonists and sympathetic stimulation. Br.J. Pharmac., 79, 205P. Google Scholar MASSINGHAM, R. (1973). A study of compounds which inhibit vascular smooth muscle contractions. Eur. J. Pharmac., 22, 75–82. 10.1016/0014-2999(73)90186-6 CASPubMedWeb of Science®Google Scholar MASSINGHAM, R. (1982). Antihypertensive Drugs: Some relationships between structure, activity and mechanisms of action. Annals de Medicina, 68 (No. 9), 825–836. Google Scholar McCALDEN, T. A. & BEVAN, J. A. (1981). Sources of activator calcium in rabbit basilar artery. Am. J. Physiol., 241, H129–H139. CASPubMedWeb of Science®Google Scholar McDONALD, T. F., PELZER, D. & TRAUTWEIN, W. (1980). On the mechanism of slow calciium block in heart. Pflugers Arch., 385, 175–179. 10.1007/BF00588699 CASPubMedWeb of Science®Google Scholar McGRATH, J. C. (1983). The variety of vascular α-adrenoceptors. Trends in Pharmac Sci., 4, 14–18. 10.1016/0165-6147(83)90267-5 CASWeb of Science®Google Scholar McGRATH, J. C., FLAVAHAN, N. A. & McKEAN, C. E. (1982). α1- and α2-Adrenoceptor-mediated pressor and chronotropic effects in the rat and rabbit. J. Cardiovasc. Pharmac., 4, S101–S107. 10.1097/00005344-198200041-00021 CASPubMedWeb of Science®Google Scholar MEISHERI, K. D., HWANG, O. & Van BREEMEN, C. (1981). Evidence for two separate Ca2+ pathways in smooth muscle plasmalemma. J. Membrane Biol., 59, 19–25. 10.1007/BF01870817 CASPubMedWeb of Science®Google Scholar MURPHY, K. M. M., GOULD, R. J. & SNYDER, S. H. (1982). Autoradiographic visualization of (3H) nitren-dipine binding sites in rat brain: localization to synaptic zones. Eur.J. Pharmac., 81, 517–519. 10.1016/0014-2999(82)90120-0 CASPubMedWeb of Science®Google Scholar MURPHY, K. M. M. & SNYDER, S. H. (1982). Calcium antagonist receptor binding sites labelled with (3H)nitren-dipine. Eur. J. Pharmac., 77, 201–203. 10.1016/0014-2999(82)90021-8 CASPubMedWeb of Science®Google Scholar NAKAYAMA, K. & KASUYA, Y. (1980). Selective abolition of Ca-dependent response of smooth and cardiac muscles by flunarizine. Jap J. Pharmac., 30, 731–742. 10.1254/jjp.30.731 CASPubMedWeb of Science®Google Scholar NAYLER, W. G. & POOLE-WILSON, P. (1981). Calcium antagonists: definition and mode of action. Basic Res. Cardiol., 76, 1–15. 10.1007/BF01908159 CASPubMedWeb of Science®Google Scholar RAHWAN, R. G., PIASCIK, M. F. & WITIAK, D. T. (1979). The role of calcium antagonism in the therapeutic action of drugs. Canad. J. Physiol. Pharmac., 57, 443–460. 10.1139/y79-069 CASPubMedWeb of Science®Google Scholar REUTER, H. (1979). Properties of two inward membrane currents in the heart. Ann. Rev. Physiol., 41, 413–424. 10.1146/annurev.ph.41.030179.002213 CASPubMedWeb of Science®Google Scholar RUFFOLO, R. R., WADDELL, J. E. & YADEN, E. L. (1982). Heterogeneity of postsynaptic alpha adrenergic recetors in mammalian aortas. J. Pharmac. exp. Ther., 221, 309–314. CASPubMedWeb of Science®Google Scholar SITRIN, M. D. & BOHR, D. F. (1971). Ca and Na interaction in vascular smooth muscle contraction. Am. J. Physiol., 220, 1124–1128. CASPubMedWeb of Science®Google Scholar SOMLYO, A. P. (1972). Excitation-contraction coupling in vertebrate smooth muscle: Correlation of ultrastructure with function. Physiologist, 15, 338–348. CASPubMedGoogle Scholar SOMLYO, A. P. & SOMLYO, A. V. (1968). Vascular smooth muscle. Pharmac. Rev., 20, 197–272. CASPubMedWeb of Science®Google Scholar SPEDDING, M. (1981). Marked differences in the effects of 'Ca2+-antagonists' on CaCl2-induced contractions in K+--depolarized smooth muscle. Br. J. Pharmac., 72, 144P. Google Scholar SPEDDING, M. (1982). Assessment of 'Ca2+-antagonist' effects of drugs in K+-depolarized smooth muscle. Naunyn-Schmied. Arch. Pharmac., 318, 234–240. 10.1007/BF00500485 CASPubMedWeb of Science®Google Scholar SPEDDING, M. (1983). The effects of changing surface charge with salicylate on the potency of calcium antagonists in smooth muscle. Br. J. Pharmac., 78, 36P. Google Scholar THORENS, S. & HAEUSLER, G. (1979). Effects of some vasodilators on calcium translocation in intact and fractionated vascular smooth muscle. Eur. J. Pharmac., 54, 79–91. 10.1016/0014-2999(79)90410-2 CASPubMedWeb of Science®Google Scholar TOWART, R. & KAZDA, S. (1980). Selective inhibition of serotonin induced contractions of rabbit basilar artery by nimodipine (Bay. e 9736) IRCS Med. Sci., 8, 206–209. CASWeb of Science®Google Scholar TOWART, R., WEHINGER, E. & MEYER, H. (1981). Effects of unsymmetrical ester substituted 1,4-dihyd-ropyridine derivatives and their optical isomers on contraction of smooth muscle. Naunyn Schmied. Arch. Pharmac., 317, 183–185. 10.1007/BF00500079 CASPubMedWeb of Science®Google Scholar TOWART, R., WEHINGER, E., MEYER, H. & KAZDA, S. (1982). The effects of nimodipine, its optical isomers and metabolities on isolated vascular smooth muscle. Arzneim. Forsch., 32, 338–345. CASPubMedWeb of Science®Google Scholar TRIGGLE, D. J. (1982). Counting Ca2+ channels. Trends in Pharmac. Sci., 3, 465–466. 10.1016/0165-6147(82)91238-X CASWeb of Science®Google Scholar TRIGGLE, D. J. & SWAMY, V. C. (1980). Pharmacology of agents that affect calcium. Chest, 78, (Supplement), 174–179. CASPubMedWeb of Science®Google Scholar Van BREEMEN, C. (1974). Relative contribution of Ca2+-efflux and cellular Ca-release during drug induced activation of the rabbit aorta. Pflugers Archiv., 348, 13–19. 10.1007/BF00587735 CASWeb of Science®Google Scholar Van BREEMEN, C., AARONSON, P. & LOUTZENHISER, R. (1979). Sodium-calcium interactions in mammalian smooth muscle. Pharmac. Rev., 30, 167–208. Google Scholar Van BREEMEN, C., AARONSON, P., LOUTZENHISER, R. & MEISHERI, K. (1980). Calcium movements in smooth muscle. Chest, 78, (Supplement), 157–165. PubMedWeb of Science®Google Scholar Van BREEMEN, C., AARONSON, P., LOUTZENHISER, R. & MEISHERI, K. (1982a). Calcium fluxes in isolated rabbit aorta and guinea-pig taenia coli. Fed. Proc., 41, 2891–2897. PubMedWeb of Science®Google Scholar Van BREEMEN, C., FARINAS, B. R., GERBA, P. & McNAUGHTON, E. D. (1972). Excitation-contraction coupling in rabbit aorta studied by the lanthanum method for measuring cellular calcium influx. Circ. Res., 30, 44–45. 10.1161/01.RES.30.1.44 PubMedWeb of Science®Google Scholar Van BREEMEN, C., HWANG, O. & CAUVIN, C. (1982b). Ca antagonist inhibition of norepinephrine stimulated Ca influx in vascular smooth muscle. In: Calcium Modulators (Eds. T. Godfraind, A. Albertini & R. Paoletti) Elsevier/North Holland. Amsterdam , 185–198. Google Scholar Van BREEMEN, C., HWANG, O. & MEISHERI, K. D. (1981). The mechanism of the inhibitory action of dil-tiazem on vascular smooth muscle contractility. J. Pharmac. exp. Ther., 218, 459–463. PubMedWeb of Science®Google Scholar Van BREEMEN, C., MANGEL, A., FAHIM, M. & MEISHERI, K. (1982c). Selectivity of calcium antagonistic action in vascular smooth muscle. Am. J. Cardiol., 19, 507–510. 10.1016/S0002-9149(82)80003-9 Web of Science®Google Scholar Van BREEMEN, C. & SIEGEL, B. (1980). The mechanism of α-adrenergic activation of the dog coronary artery. Circ. Res., 46, 426–429. 10.1161/01.RES.46.3.426 PubMedWeb of Science®Google Scholar VANHOUTTE, P. M. & BOHR, D. F. (1981). Calcium entry blockers and the cardiovascular system. Fed. Proc., 40, 2851. Web of Science®Google Scholar Van MEEL, J. C. A., DEJONGE, A., KALKMAN, H. O., WILFFERT, B., TIMMERMANS, P. B. M. W. M. & Van ZWIETEN, P. A. (1981a). Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic α2-adrenoceptors. Naunyn. Schmied. Arch. Pharmac., 316, 288–293. 10.1007/BF00501359 CASPubMedWeb of Science®Google Scholar Van MEEL, J. C. A., DE JONGE, A., WILFFERT, B., KALKMAN, H. O., TIMMERMANS, P. B. M. W. M. & Van ZWIETEN, P. A. (1981b). Vascular smooth muscle contraction initiated by postsynaptic α2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur. J. Pharmac., 69, 205–208. 10.1016/0014-2999(81)90415-5 CASPubMedWeb of Science®Google Scholar Van MEEL, J. C. A., DE ZOETEN, K., TIMMERMANS, P. B. M. W. M. & Van ZWIETEN, P. A. (1982a). Impairment by nifedipine of vasopressor responses to stimulation of postsynaptic α2-adrenoceptors in ganglion-blocked rabbits. Further evidence for the selective inhibition of postsynaptic α2-adrenoceptor-induced pressor responses by calcium antagonists. J. Auton. Pharmac., 2, 13–20. 10.1111/j.1474-8673.1982.tb00465.x PubMedWeb of Science®Google Scholar Van MEEL, J. C. A., TIMMERMANS, P. B. M. W. M. & Van ZWIETEN, P. A. (1982b). L'interaction entre les antagonistes du calcium et les α-receptors postsynap-tiques vasculaires. J. Pharmac., (Paris), 13, 367–379. Google Scholar Van MEEL, J. C. A., TIMMERMANS, P. B. M. W. M. & Van ZWIETEN, P. A. (1983). Postjunctional α2-adrenoceptors and calcium entry blockade in the isolated perfused hindquarters of the rat. Br. J. Pharmac, (in press). Google Scholar Van NEUTEN, J. M., Van BEEK, J. & JANSSEN, P. A. J. (1978). Effect of flunarizine on calcium-induced responses of peripheral vascular smooth muscle. Arch. int. Pharmacodyn, 232, 42–52. Google Scholar Van NEUTEN, J. M. & VANHOUTTE, P. M. (1981). Selectivity of calcium antagonism and serotonin antagonism with respect to venous and arterial tissues. Angiology, 32, 476–484. 10.1177/000331978103200704 PubMedWeb of Science®Google Scholar WADSWORTH, R. M. & MOSS, J. P. Time course of the effect of flunarizine on rabbit isolated vascular muscle. Eur.J. Pharmac., 85, 207–209. Google Scholar WEISS, G. B. (1981). In New Perspectives on Calcium Antagonists. (ed. G.B. Weiss). Am. Physiol. Soc. Clin. Phys. Series. Bethesda , 83–94. Google Scholar WESTON, A. H. (1978). The effect of noradrenaline on electrical activity and calcium fluxes in rat portal vein. In E. Szebadi CM Bradshaw & P. Bevan (Eds.) Recent advances in the pharmacology of adrenoceptors. Elsevier. Amscerdam . pp. 15–22. Google Scholar WINQUIST, R. J., WEBB, R. C. & BOHR, D. F. (1981). Calcium antagonism is no rose. Fed. Proc., 40, 2852–2853. CASPubMedWeb of Science®Google Scholar ZELIS, R. & FLAIM, S. F. (1981). 'Calcium influx blockers' and vascular smooth muscle: Do we really understand the mechanisms Annals of Internal Med., 94, 124–126. 10.7326/0003-4819-94-1-124 CASPubMedWeb of Science®Google Scholar Citing Literature Volume3, Issue3September 1983Pages 219-232 ReferencesRelatedInformation

Referência(s)